Microenvironmental Behaviour of Nanotheranostic Systems for Controlled Oxidative Stress and Cancer Treatment

The development of smart, efficient and multifunctional material systems for diseases treatment are imperative to meet current and future health challenges. Nanomaterials with theranostic properties have offered a cost effective and efficient solution for disease treatment, particularly, metal/oxide based nanotheranostic systems already offering therapeutic and imaging capabilities for cancer treatment. Nanoparticles can selectively generate/scavenge ROS through intrinsic or external stimuli to augment/diminish oxidative stress. An efficient treatment requires higher oxidative stress/toxicity in malignant disease, with a minimal level in surrounding normal cells. The size, shape and surface properties of nanoparticles are critical parameters for achieving a theranostic function in the microenvironment. In the last decade, different strategies for the synthesis of biocompatible theranostic nanostructures have been introduced. The exhibition of therapeutics properties such as selective reactive oxygen species (ROS) scavenging, hyperthermia, antibacterial, antiviral, and imaging capabilities such as MRI, CT and fluorescence activity have been reported in a variety of developed nanosystems to combat cancer, neurodegenerative and emerging infectious diseases. In this review article, theranostic in vitro behaviour in relation to the size, shape and synthesis methods of widely researched and developed nanosystems (Au, Ag, MnOx, iron oxide, maghemite quantum flakes, La2O3−x, TaOx, cerium nanodots, ITO, MgO1−x) are presented. In particular, ROS-based properties of the nanostructures in the microenvironment for cancer therapy are discussed. The provided overview of the biological behaviour of reported metal-based nanostructures will help to conceptualise novel designs and synthesis strategies for the development of advanced nanotheranostic systems.


Introduction
Nanoparticles (NPs) offer a unique combination of physiochemical properties for the treatment of various disease. Their multifunctional use in therapeutics, imaging, drug delivery and diagnostics is increasing day by day [1,2]. In the last decade, oxidebased nanotheranostic systems have rapidly expanded and emerged as a leading research field. The integration of therapeutic and imaging capabilities into a single nano-entity can form theranostic nanostructures [3]. An efficient theranostic NPs drug system must have requisite biocompatibility, biodegradability and adequate clearance. Other properties, such as tumour accumulation, drug delivery, immune system escape and selective targeting are also matters of interest in disease therapy and diagnostics [4]. In view of the theraputic case of tumour cells [17,18]. In addition, they can be efficient carriers of drugs for th lective treatment of disease without harming the normal neighbouring tissues or Enhanced permeability (EPR) and retention in the malignant tumour are also desire efficient drug responses. In the case of NP-based immunotherapy, the system is desi for the controlled drug release, generation or scavenging of ROS in the complex tu microenvironment by exploiting their enzymatic, pH, hypoxia, ultrasound, electricit light-dependent response [19][20][21]. Nanoparticles' internalisation or delivery to sp sites is usually obtained by passive and active targeting. Passive targeting involve passage of nanoparticles through the leaky vasculature and accumulation within mour. In active targeting, molecules/ligands are attached to the NP's surface for sp receptor acceptance [22]. Antioxidants, SOD conjugated polymers or metal-based NP employed as active and passive targeting simultaneously for intercellular and extra lar ROS management [8,23,24]. Cell culture studies can provide detailed inform about the biological process at the basic level in an organism. The cell culture mode very useful in evaluating the toxicology and physiology of NPs/drugs, Figure 1. They an important role in the development of vaccines, drugs, bioactive substances, diagn techniques, theranostic agents, food ingredients and cosmetics [25]. This review m focuses on the passive activity of NPs in disease (malignant) conditions with referen normal cellular behaviour to record their effectiveness.
In the present article, the in vitro biological effects of nanotheranostic structures, as (Au), silver (Ag), manganese (Mn)-based NPs, iron oxide nanostructures, oxygen cient La2O3, nanodots of cerium oxide, surface-encrusted nanostructures, magh quantum flakes, indium tin oxide (ITO), tantalum oxide (Ta2O3) and magnesium (MgO) are summarised. The morphology and synthesis methods of nanostructure also outlined. In particular, the biocompatible nature in relation to synthesis strate detailed in the current review. They show promising results in the treatment of va types of cancers and other emerging diseases. Advanced nano-oxide structures will the future of medicine to more compact, safe and economical therapeutic and diagn systems. The present review can provide a platform for the selection and design efficient nanomedicine or materials system to meet the challenges of current and eme diseases.  In the present article, the in vitro biological effects of nanotheranostic structures, such as (Au), silver (Ag), manganese (Mn)-based NPs, iron oxide nanostructures, oxygendeficient La 2 O 3 , nanodots of cerium oxide, surface-encrusted nanostructures, maghemite quantum flakes, indium tin oxide (ITO), tantalum oxide (Ta 2 O 3 ) and magnesium oxide (MgO) are summarised. The morphology and synthesis methods of nanostructures are also outlined. In particular, the biocompatible nature in relation to synthesis strategy is detailed in the current review. They show promising results in the treatment of various types of cancers and other emerging diseases. Advanced nano-oxide structures will shift the future of medicine to more compact, safe and economical therapeutic and diagnostic systems. The present review can provide a platform for the selection and design of an efficient nanomedicine or materials system to meet the challenges of current and emerging diseases. Minai et al. reported the increased generation of ROS during exposure to laser pulses in the presence of Au NPs [40]. After irradiation (8 pulses) in the presence of Au NPs, Burkitt lymphoma cells showed an increased amount of ROS (green dots, Figure 3a) in comparison to the control, as observed by fluorescence microscopy. A relative percentage increase in ROS with and without NPs and laser irradiations is shown in Figure 3b [40]. Similarly, fluorescence imaging on NP-treated epithelial breast cancer cells showed increased green fluorescence after laser pulse exposure (Figure 3c). In the case of 06 pulses of laser irradiation and NP treatment of epithelial breast cancer cells, about a 55% increase in apoptotic cells resulted, compared to the control cells ( Figure 3d) [40].  Table 1. Cellular responses of different cell culture models with reference to size, shape and synthesis of Au NPs.
Human liver cell line (HL7702 cells) Spherical (5-100 nm) Citrate reduction Decrease in cytosolic GSH, depolarisation of transmembrane potential in the mitochondria, followed by apoptosis and death [46].

MRC human foetal lung fibroblast cell
Unknown shape (20 nm) Citrate reduction Increase in oxidative stress, downregulation of cell cycle gene, inhibition of cell proliferation and DNA damage [27,49].

Human colorectal adenocarcinoma cells (HT29)
Unknown shape (50-100 nm) Photonic Technology (IPHT Jena, Germany) Inhibition of cell proliferation and angiogenesis, reduction in cell viability [57,58].  showing the percentage of necrotic (red) and apoptotic (green) cells. Where * p ˂ 0.0003. Images and graphs are reproduced with permission from [40], copyright 2013, Springer Nature, and representing the overall trend of results. Table 1. Cellular responses of different cell culture models with reference to size, shape and synthesis of Au NPs.
Human liver cell line (HL7702 cells) Spherical (5-100 nm) Citrate reduction Decrease in cytosolic GSH, depolarisation of transmembrane potential in the mitochondria, followed by apoptosis and death [46]. Upregulation of apoptotic genes (including bax, showing the percentage of necrotic (red) and apoptotic (green) cells. Where * p < 0.0003. Images and graphs are reproduced with permission from [40], copyright 2013, Springer Nature, and representing the overall trend of results.

Silver Nanoparticles
Due to well-established antimicrobial properties, Ag NPs are widely used in many consumer products, such as toothpaste, shampoos, washing powders, kitchen utensils, toys, filters and deodorants [59,60]. It is very important to evaluate the potential toxicity for safe and effective use as applications of Ag NPs are rapidly expanding. In vitro studies of normal and tumour cell culture in the presence of Ag NPs can be performed for the comparison of potential toxicity and therapy. The cytotoxicity of prepared NPs varies due to the different synthesis methods and functionalisation of NPs. The best approach is to Nanomaterials 2022, 12, 2462 7 of 40 compare the cytotoxic effects on cellular components (in vitro studies) using naked Ag NPs. The effect of Ag NPs on different normal and tumour cell lines are summarised in Table 2. It is highly desired that NPs only induce toxicity in tumour cells, such as human liver cancer cells (HepG2), human breast cancer cell lines (MDA-MB 231), human embryonic kidneys (HEK293T) cells, human neuroblastomas (SH-SY5Y) cell line and others, whereas therapeutic or neutral effects are required in normal cells (e.g., human macrophages and human keratinocyte (HaCaT) cell lines). Ag + addition results in modifications of DNA base pairs, deoxyribose fragmentations and DNA strand breakups. Due to the formation of two coordination complexes in DNA (high-energy and ground-energy states) by Ag + , a modification in the base pairs of DNA by a reaction with double and triple hydrogen bonds can be the result [61]. DNA base pairing and the changes in other organelles by Ag + is shown in Figure 4. The Ag NPs can easily ionise to generate ROS to stimulate inflammatory responses through phagocytosis. Park et al. reported the generation of ROS in macrophage cells, and the activated macrophages increased the TNF-α secretion that led to cell membrane damage and apoptosis [62]. The green synthesis and surface coating of Ag NPs can reduce the toxic effect on healthy cells. Chitosan-coated Ag NPs exhibited good biocompatibility and efficient cellular internalisation in human embryonic cells (HEKs), as reported by Boca et al. [63]. The biogenic synthesis using different microorganisms where Ag + is reduced to Ag 0 in the presence of protein enzymes have been reported in several studies [64][65][66]. The Ag NPs synthesised by these methods showed increased biocompatibility, cellular uptake, antimicrobial properties and secretion [67]. The mechanisms of cellular internalisation and toxicity of Ag NPs are depicted in Figure 4. microorganisms where Ag + is reduced to Ag 0 in the presence of protein enzymes have been reported in several studies [64][65][66]. The Ag NPs synthesised by these methods showed increased biocompatibility, cellular uptake, antimicrobial properties and secretion [67]. The mechanisms of cellular internalisation and toxicity of Ag NPs are depicted in Figure 4. An in vitro study of Rubus-conjugated Ag NPs (RAg NPs) using an MCF-7 cell line exhibited increased cell death at higher concentrations (10 µg mL −1 ) compared to lower concentrations (5 µg mL −1 ) and the control (Figure 5a, reported by George et al.) [68]. The treatment with Ag NPs disrupted the mitochondrial respiratory chain reactions, which enhanced ROS generation, DNA damage and changes in ATP levels. An increased cytotoxicity determined by a lactate dehydrogenase (LDH) assay was observed in the treated cells ( Figure 5b). Increased ROS generation was also witnessed in the dose-dependent NP treatment, as the highest number of ROS formations resulted during the 10 µg mL −1 treatment than at lower concentrations (Figure 5c,d). In the treated cells (MCF-7), cytochrome c and caspase-3/7 activity upregulation was observed compared to the control cells (Figure 5e,f) [68]. The present study concluded that RAg NPs enhanced ROS-dependent toxicity and cellular apoptosis in cancer cells [68]. An in vitro study of Rubus-conjugated Ag NPs (RAg NPs) using an MCF-7 cell line exhibited increased cell death at higher concentrations (10 µg mL −1 ) compared to lower concentrations (5 µg mL −1 ) and the control (Figure 5a, reported by George et al.) [68]. The treatment with Ag NPs disrupted the mitochondrial respiratory chain reactions, which enhanced ROS generation, DNA damage and changes in ATP levels. An increased cytotoxicity determined by a lactate dehydrogenase (LDH) assay was observed in the treated cells (Figure 5b). Increased ROS generation was also witnessed in the dose-dependent NP treatment, as the highest number of ROS formations resulted during the 10 µg mL −1 treatment than at lower concentrations (Figure 5c,d). In the treated cells (MCF-7), cytochrome c and caspase-3/7 activity upregulation was observed compared to the control cells (Figure 5e,f) [68]. The present study concluded that RAg NPs enhanced ROS-dependent toxicity and cellular apoptosis in cancer cells [68]. Nanomaterials 2022, 12, x FOR PEER REVIEW 9 of 42 Figure 5. (a) Light microscopy images of MCF-7 cells depicting morphological changes after treatment with R-Ag NPs (10 µg mL −1 ) compared to control; (b) cytotoxicity of R-Ag NPs at 2.5, 5 and 10 µg mL −1 concentrations towards MCF-7 cells with reference to control measured by lactate dehydrogenase (LDH) activity assay; (c) fluorescent images of MCF-7 cells after treatment with R-Ag NPs at a 10 µg mL −1 concentration indicating the ROS presence compared to the control; (d) ROS generation in terms of DCF intensity measurements of treated cells at 2.5, 5 and 10 µg mL −1 concentrations of R-Ag NPs compared to the control; (e) caspase-3/7 activity measured as a function of caspase-dependent activity of treated cells for 24 h with reference to the control and (f)cytochrome-C activity measurement of treated cell with reference to the control. Where *** p ˂ 0.001, ** p ˂ 0.01 and * p ˂ 0.05. Images and graphs are reproduced with permission from [68], copyright 2018, Springer Nature, and represent the overall trend of results. (d) ROS generation in terms of DCF intensity measurements of treated cells at 2.5, 5 and 10 µg mL −1 concentrations of R-Ag NPs compared to the control; (e) caspase-3/7 activity measured as a function of caspase-dependent activity of treated cells for 24 h with reference to the control and (f) cytochrome-C activity measurement of treated cell with reference to the control. Where *** p < 0.001, ** p < 0.01 and * p < 0.05. Images and graphs are reproduced with permission from [68], copyright 2018, Springer Nature, and represent the overall trend of results.

Manganese Oxide Nanostructures
Many metal and metal oxide NPs release toxic ions after cellular internalisation, depending upon the pH and the medium. The breakup of H 2 O 2 or other species by NPs generate ROS, which lead to cellular oxidative stress [81]. An increase in oxidative stress in tumour cells causes cellular apoptosis and a decrease in proliferation. The oxidative burst is commonly employed to kill tumour cells. In the case of normal cells, oxidative stress is very dangerous because it can damage healthy cells. The toxic metal ions cause membrane leakage, inflammation, cell signalling cascades, protein damage and protein unfolding, DNA damage and mitochondrion dysfunction [82,83].
Manganese oxide (MnO x ) exists in more than one oxidation state (+2, +3, +4, +6, and +7). Due to a variety of oxidation states, the compounds in oxidation state +3 and higher oxidation states are usually involved in redox reactions. Divalent and trivalent oxidation states are the most stable, whereas other oxidation states undergo redox changes. MnO 2 finds applications as catalysts, magnetic resonance imaging, tissue imaging, biosensors, molecular adsorption, drug delivery and cancer immunotherapy [84,85]. The toxicity of manganese metal and its oxide varies and mainly depends upon the synthesis process, size, shape and oxidation state.
Manganese in an elemental form participates as a cofactor in certain enzymes, such as superoxide dismutase lyases, and tranferases [86]. In enzymatic activity, Mn +3 changes to Mn +2 during the dismutation of superoxide radicals into molecular oxygen, and catalysed by the SOD2 enzyme. Similarly, the superoxide and hydroxyl radicals dismutate into H 2 O 2 , and Mn +3 transforms into Mn +2 [87,88].
However, an increased concentration might produce a neural disorder and adverse effect on human health. It has been reported that Mn-based NPs can enter dopaminergic neuronal cells and cause neurotoxicity [89]. Studies performed on breast cancer cells, human lung adenocarcinomas and glioblastomas reported the formation of ROS and LDH leakage [90]. Similarly, in a study on rat type-II epithelial cells, Mn 2 O 3 NPs interacted with glutathione (GSH) and induced apoptosis [91]. A summary of Mn-based NPs' effects on different cell lines is presented in Table 3. It can be observed from the data ( Table 3) that Mnbased NPs produce neural toxicity, biochemical alterations, ROS, oxidative stress, cellular apoptosis and damage in cell membranes and other organelles. MnO crystals can also be used as contrast agents in T1-and T2-weighted images. T1-weighted image contrast relies on signal enhancement (positive effect), whereas T2-contrasting involves the reduction in signals (negative effect). T1 is more suited to the study of the morphological structure, and T2-contrasting is suited to pathological conditions. Mn-based NPs are theranostic agents; however, their toxicity must be carefully evaluated to suit their use for particular applications [92].
Recently, Mn-based composite nanostructures with improved biocompatibility, therapeutic and imaging capabilities have been synthesised. A dual-modality contrast agent MnWO 4 nanostructure has been synthesised by Dong et al. [93]. The reported structure exhibited excellent dispersibility, biocompatibility and superior contrast efficacy, with applications as CT and T1-weighted MRI agents simultaneously.
There is an increased interest in the development of biodegradable nano-thernasotic platforms for antitumour applications. Yang et al. reported the synthesis of a hollow manganese dioxide (H-MnO 2 ) nanosystem for controlled drug release and imaging [94]. A high-resolution TEM image ( Figure 6a) shows polyethylene glycol (PEG) spherical H-MnO 2 nanoparticles. The hollow NPs (H-MnO 2 -PEG) was further loaded with Ce6 and DOX drugs. The drug loading capability of H-MnO 2 -PEG NPs at different feeding rates of Ce6 and DOX is shown in Figure 6b. The treatment of 4TI cells with drug (Ce6)-loaded H-MnO 2 -PEG NPs in the presence of N 2 and O 2 after 660 nm light irradiation showed increased toxicity at increased drug concentrations (Figure 6c) [94]. It can be concluded from the toxicity data that H-MnO 2 -PEG NPs loaded with Ce6 can serve as effective PDT agents, even in a hypoxic environment. The confocal microscopy ( Figure 6d) of 4TI cells treated with H-MnO 2 -PEG NPs loaded with Ce6 and DOX examined in blue, green and red channels (corresponding to DAPI, Ce6 and DOX, respectively) indicated the imaging capability of the developed system [94]. The developed biodegradable nanoplatform (H-MnO 2 -PEG NPs loaded with Ce6 and DOX) can be dissociated under reduced pH conditions and the tumour microenvironment (tumour hypoxia) to release loaded therapeutics, and can aid in the decomposition of cellular H 2 O 2 to overcome tumour hypoxia to generate ROS [94].  ROS generation induced oxidative stress, apoptosis (caspase-3 activation), PS translocation and fragmentation of chromosomes [98].

Iron Oxide Nanostructures
Iron oxide is usually formed in two major forms (Fe II and Fe III) based on oxide structures, which include magnetite (Fe 3 O 4 ), hematite (Fe 2 O 3 /α-Fe 2 O 3 ) and maghemite (γ-Fe 2 O 3 ). These oxides exist naturally in large quantities and are widely synthesised for their numerous applications. Fe 3 O 4 and γ-Fe 2 O 3 are extensively used in the field of biomedicine due to their paramagnetic/superparamagnetic nature and involvement in various biological processes. Iron oxide magnetic nanoparticles (IOMNPs) provide a theranostic platform where they can be exploited for diagnostic purposes, such as magnetic resonance imaging (MRI), and therapeutic purpose, such as drug delivery, magnetic cell separation, protein purification and bio-catalysts [101][102][103]. IOMNPs can be synthesised in different sizes and shapes using a variety of synthesis methods. Due to their widespread application and varying morphologies and surface properties, the toxicity of IOMNPs must be evaluated in relation to different conditions and body components [104]. The in vitro toxicity of IOMNPs varies with pH conditions and cell types. The Fenton reaction is a major ROS generating event leading to oxidative stress and cellular apoptosis. The Fenton reaction involves the reaction of Fe(II) with H 2 O 2 to generate OH − and OH • radicals. The over production of ROS can cause damage to DNA and other cellular organelles (Table 4).
In several studies, it has been reported that tumour cells have high levels of ROS [105][106][107]. The major factors contributing to increased ROS might include oncogenic stimulation, mitochondrial malfunctions, increased metabolic activity and other dysregulated activities in the cells [105]. It appears advantageous that a high level of ROS favours the growth of cancer cells by activating several stress kinase pathways [108]. In addition, cancer cells can adopt high levels of ROS due to the presence of oncogene c-Myc, which increases the tolerance level by activating transcriptional genes for GSH biosynthesis in response to H 2 O 2 [109]. It is apparent that increased levels of ROS and oncogenic transformation result in the increased sensitivity of the cells to generate ROS [110]. Several chemicals and nanomaterials, such as phenylethyl isothiocyanate, titanium-based materials and piperlongumine increase ROS levels and selectively target tumour cells, and do not cause much damage to normal cells [106,110]. On the other hand, for increased ROS levels, cells are treated with certain chemicals, such as N-acetyl-l-cysteine, to scavenge ROS [111]. Thus, selective treatment with ROS generation/scavenging in malignant cells while protecting normal cells is an effective method for cancer therapy.
Iron is an important factor in the ROS-linked homeostasis of normal cells and can cause dysregulation to result in tumorigenesis. Iron regulates different functions in cells of different tissues in the body. The common Fe-related phenomena and their in vitro effects are presented in Figure 7, and are also described as follows:

• Ferroptosis
Iron-dependent oxidative cell death is termed as ferroptosis. It is triggered by structurally different small molecules, such as erastin, RSL3 and sulfasalazine. Ferroptosis is different from apoptosis, autophagy and other forms of necrosis [112,113]. The fundamental details of iron oxide involvement in ferroptosis are not clear. It is hypothesised that the inhibition of cysteine uptake causes the depletion of the endogenous antioxidant tripeptide glutathione, which causes the accumulation of iron-dependent ROS and leads to cell death [112,114]. Ferroptosis can be prevented by using iron chelators (such as deferoxamine and lipophilic antioxidants, i.e., vitamin E and Trolox) [112,115].

• Oxytosis
Oxytosis or oxidative glutamate toxicity is linked to iron and is observed in certain brain cells in the absence of cystine [116]. Oxytosis in neural cells initially involves membrane lipid damage and results in cell death, including LOX activation, Ca 2+ influx into the cell, overproduction of mitochondrial ROS and fragmentation of mitochondrion [113,114,116]. Iron-dependent oxidative cell death was observed in premature oligodendrocytes cells using high concentrations of glutamate or having the absence of cysteine. In the nervous system, the depletion of premyelinating cells causes periventricular leukomalacia (PVL) disease, which is characterised by white-matter lesions within the brain and acts as a precursor for cerebral palsy development [117,118].

• Intercellular iron accumulation as a mediator of cell death
According to the research reports in recent years, liver toxicity is caused by iron overload and can be ameliorated by mitochondrially targeted oxidation [119]. It is important to understand that high levels of iron are not always harmful for cell viability and proliferation because, sometimes, iron overload contribute to cell death in certain cell types and tissues, and it may increase cell proliferation and viability. Antiproliferative and proliferative functions can also be performed through cell-nonautonomous or cell-autonomous effects on cell mutation and tissue microenvironments, cell signalling and iron-dependent enzyme function. For example, Parkinson's disease is linked to the depletion of the Tau protein (linked to iron export) by iron accumulation [114,120].
Neurodegenerative disease are increasing rapidly; they are associated with iron accumulation within neurons [121]. An accumulation of iron generates ROS through enhanced Fenton chemistry mediation. In Parkinson's disease, dopaminergic neuronal populations are susceptible to degeneration and involve increased amounts of mitochondrion ROS [122,123]. Iron chelators can be employed to prevent high levels of ROS production via the autophagy of ROS producing mitochondrion. Thus, iron chelators or ROS scavengers lower the damaging levels of ROS and, hence, oxidative stress [122].

• Extracellular iron accumulation as a mediator of cell death
Iron acts as mediator for signal responses in the excitotoxic death of cortical neuronal populations of a mouse in response to N-methyl-d-aspartate (NMDA). The required iron is transported from the outside of the cell by an iron transporter divalent metal transporter 1 (DMT1) [127]. An analysis of NDMA treatment results show that increased ROS production and oxidative stress induce cell death. It is quite obvious that iron import and NOXderived ROS production enhance ROS-mediated neural cell deaths [114,128]. The common phenomena of cellular toxicity due to iron overload and Fenton chemistry are depicted in Figure 7.

Recently Developed Theranostic Nanostructures
Over the past decade, various inorganic nanostructures and quantum structures have been developed and investigated for thernostics applications. In particular, superparamagnetic NPs, silicon spheres, transition metals and lanthanide-based quantum structures are of interest for biological applications. The development of advanced size-and shapecontrolled nanotheranostics require novel or modified synthesis techniques. As we know, synthesis techniques play an important role in the surface property tuning, size and shape of NPs. Nanodots or quantum dots (sized 2-20 nm) offer a wide range of properties in diverse fields of applications due to their extremely high surface area, stability and efficient catalytic, magnetic and electrical properties. Transition metals and lanthanide series elements are the focus of current research for the development of novel nano/quantum structures. Synthesis conditions can stabilise the new phases in the formed quantum structures. It can also be very convenient to introduce oxygen deficiency to the developed nanostructures.

Maghemite Nano-and Quantum Structures
The properties of superparamagnetic iron oxide nanoparticles (SPIONs) depend upon size, shape and iron oxide structure. The particle/crystal size and shape affect the NPs' internalisation, retention, circulation and toxicity [136,137]. It has been shown that rodshaped NPs present higher toxicity than sphere-shaped NPs. [138,139]. The oxidation state (Fe +3 , Fe +2 ) in SPIONs also affects in vitro and in vivo cytotoxicities. In many studies, it has been shown that γ-Fe 2 O 3 -nano/quantum structures did not cause much toxicity or DNA damage (Table 5), and exhibited superparamagnetic behaviour, Figure 8 [138,140].

Recently Developed Theranostic Nanostructures
Over the past decade, various inorganic nanostructures and quantum structures have been developed and investigated for thernostics applications. In particular, superparamagnetic NPs, silicon spheres, transition metals and lanthanide-based quantum structures are of interest for biological applications. The development of advanced size-and shape-controlled nanotheranostics require novel or modified synthesis techniques. As we know, synthesis techniques play an important role in the surface property tuning, size and shape of NPs. Nanodots or quantum dots (sized 2-20 nm) offer a wide range of properties in diverse fields of applications due to their extremely high surface area, stability and efficient catalytic, magnetic and electrical properties. Transition metals and lanthanide series elements are the focus of current research for the development of novel nano/quantum structures. Synthesis conditions can stabilise the new phases in the formed quantum structures. It can also be very convenient to introduce oxygen deficiency to the developed nanostructures.

Maghemite Nano-and Quantum Structures
The properties of superparamagnetic iron oxide nanoparticles (SPIONs) depend upon size, shape and iron oxide structure. The particle/crystal size and shape affect the NPs' internalisation, retention, circulation and toxicity [136,137]. It has been shown that rod-shaped NPs present higher toxicity than sphere-shaped NPs. [138,139]. The oxidation state (Fe +3 , Fe +2 ) in SPIONs also affects in vitro and in vivo cytotoxicities. In many studies, it has been shown that γ-Fe2O3-nano/quantum structures did not cause much toxicity or DNA damage (Table 5), and exhibited superparamagnetic behaviour, Figure 8 [138,140]. Recently, quantum dots have gained much interest due to their broad range of excitation and absorption properties, high surface area, excellent photoluminescence and photostability. When the size of magnetic NPs reaches < 10 nm, they start behaving as a single magnetic domain with superparamagnetic behaviour [142][143][144][145]. Quantum structures can be employed as fluorescent agents in in vitro and in vivo biomedical imaging [146].
Among iron oxide-based nanostructures, γ-Fe2O3 has excellent magnetic properties, biocompatibility and pH-dependent selective toxicity [141,147]. It has been reported that γ-Fe2O3 can be employed as an effective nanozyme for both peroxidases, such as activity (at acidic pH), and catalases, such as mimetic activity (at neutral pH) [141,147].  Recently, quantum dots have gained much interest due to their broad range of excitation and absorption properties, high surface area, excellent photoluminescence and photostability. When the size of magnetic NPs reaches < 10 nm, they start behaving as a single magnetic domain with superparamagnetic behaviour [142][143][144][145]. Quantum structures can be employed as fluorescent agents in in vitro and in vivo biomedical imaging [146].
Among iron oxide-based nanostructures, γ-Fe 2 O 3 has excellent magnetic properties, biocompatibility and pH-dependent selective toxicity [141,147]. It has been reported that γ-Fe 2 O 3 can be employed as an effective nanozyme for both peroxidases, such as activity (at acidic pH), and catalases, such as mimetic activity (at neutral pH) [141,147].  Figure 9d. An increased level of ROS was observed in MDA-MB-231 and A375 cells compared to HaCaT cells. A higher cellular uptake of MQFs was also observed in malignant cells compared to non-malignant cells, as reported in the present study [141]. malignant cells (MDA-MB-231 and A375) than non-malignant cells (HaCaT) (Figure 9g). The ROS scavenging/generation properties of γ-Fe2O3 quantum flakes (MQFs) compared to the negative (cells only) and positive (H2O2) controls are presented in Figure 9d. An increased level of ROS was observed in MDA-MB-231 and A375 cells compared to HaCaT cells. A higher cellular uptake of MQFs was also observed in malignant cells compared to non-malignant cells, as reported in the present study [141]. These magnetic quantum dots (MQDs) are capable of inhibiting tumour growth by ROS augmentation to induce selective toxicity ( Figure 8, Table 5) [141,143,148,149]. Table 5. Size, shape and synthesis method of γ-Fe2O3 NPs and their in vitro biological effect on malignant and non-malignant cell lines.

Cell Line NP Size and Shape Synthesis Method Effect
He La cells γ-Fe2O3, spherical shape (<20 nm) Microwave-assisted hydrothermal No significant toxicity, generation of ROS, enhanced oxidative stress, application as multimodal (ROS and hyperthermia) anticancer therapy [138].  These magnetic quantum dots (MQDs) are capable of inhibiting tumour growth by ROS augmentation to induce selective toxicity ( Figure 8, Table 5) [141,143,148,149].

Indium Tin Oxide (ITO) Nanostructure in the Biological Field
In the last few years, ITO remained one of the most researched materials for a variety of applications. It is an n-type semiconductor with a band gap of 3.2 eV [151,152]. It finds its main applications as liquid crystal display devices, electrochromic cells, solar cells and sensor modules [151,153]. There is limited research on ITO NPs for biomedical applications. In the biomedical field, it is mostly employed in biosensors, where they are exploited in the electrochemistry of biomolecules and for the immobilisation of immunoreagents [154]. Hu et al. reported a glucose biosensor based on an ITO/Au NP bilayer composite, which showed excellent electrochemical behaviour [155]. This sensor exhibited high sensitivity to the detection of the HIV virus in a label-free system with only a small amount of reagent required, and also showed high stability. In many studies, ITO was reported as a substrate layer with other metal oxide NPs (such as ZnO, Au, Ag, Pt, Ni, Fe 2 O 3 NPs) for the development of biosensors for a range of biomedical applications [156]. Recently, ITO NPs have been reported by Hsu et al. as theranostic agents for the treatment of cancer, Figure 10 [157]. Oxygen-deficient ITO NPs were prepared by the chemical precipitation method, followed by calcination at 400 • C [157]. The modification of the surface structure affects the physiochemical properties of NPs. ITO NPs can be employed in biomedical imaging due to their intrinsic fluorescent properties. The band gap and quantum size effect can also play important roles in the fluorescent-related imaging of ITO [157][158][159]. The study also featured the fluorescent and anatomical contrast properties of the NPs (Figure 11) for computed tomography (CT) imaging. The study proposed that ITO NPs can be theranostic agents for the selective treatment of cancer based upon oxidative stress augmentation and imaging capability [157].  Table 6, and the mechanism is shown in Figure 11 [157]. According to the results, ITO NPs induced selective toxicity in MDA-MB-231 and MCF-7 cell lines by ROS generation, which caused higher oxidative stress in comparison to non-malignant MCF-10A cell lines, shown in Figure 10b,c. Fluorescence microscopy revealed ITO NP internalisation, as shown in Figure 10a. The authors found that ITO NPs not only generated/scavenged ROS depending upon the tumour microenvironment, but also provided fluorescent imaging capabilities in in vitro assays. ITO-based NP systems can provide successful selective tumour treatment if synthesised through controlled or functionalised parameters [157].  The study also featured the fluorescent and anatomical contrast properties of the NPs (Figure 11) for computed tomography (CT) imaging. The study proposed that ITO NPs can be theranostic agents for the selective treatment of cancer based upon oxidative stress augmentation and imaging capability [157].  The study also featured the fluorescent and anatomical contrast properties of the NPs ( Figure 11) for computed tomography (CT) imaging. The study proposed that ITO NPs can be theranostic agents for the selective treatment of cancer based upon oxidative stress augmentation and imaging capability [157].

Doped Cerium and Nanodot-Encrusted Structures
Cerium (Ce) is a lanthanide series element with 4f shielded electrons, which contribute to excellent physiochemical properties. The most common oxidation states of Ce are Ce +3 and Ce +4 . [160]. Due to the special electronic configuration and reversible switching between oxidation states (Ce +3 and Ce +4 ), it is an attractive material for many applications, such as UV absorption, fuel cells, fuel oxidation, catalysis, polishing and others [161][162][163][164]. In the biomedical field, cerium oxide NPs have attracted special interest due to their regenerative and multi-enzymatic properties for ROS scavenging [163,165]. Bulk cerium oxide mainly consists of Ce +4 , whereas in nano form, a considerable amount of Ce +3 is present, which enhances its catalytic properties and biological role [166,167]. Cerium NPs have been studied in different cell lines and animals, and they exhibited biocompatibility. Cerium NPs have advantages over other NP systems due to their wide range of therapeutic and imaging capabilities. The major factor that contributes towards the wide range of biomedical properties in cerium nanostructures is the reversible switching between Ce +4 and Ce +3 oxidation states [168]. An increased level of Ce +3 in the CeO 2 nanostructure enhances the photocatalytic activity by reducing the band gap of CeO 2 . Oxygen vacancies help to increase the level of Ce +3 by preventing the recombination of charge centres. Regenerative nano-ceria oxidation-reduction cycles for ROS scavenging proceed, as presented in Figure 12: In the biomedical field, cerium oxide NPs have attracted special interest due to their regenerative and multi-enzymatic properties for ROS scavenging [163,165]. Bulk cerium oxide mainly consists of Ce +4 , whereas in nano form, a considerable amount of Ce +3 is present, which enhances its catalytic properties and biological role [166,167]. Cerium NPs have been studied in different cell lines and animals, and they exhibited biocompatibility. Cerium NPs have advantages over other NP systems due to their wide range of therapeutic and imaging capabilities. The major factor that contributes towards the wide range of biomedical properties in cerium nanostructures is the reversible switching between Ce +4 and Ce +3 oxidation states [168]. An increased level of Ce +3 in the CeO2 nanostructure enhances the photocatalytic activity by reducing the band gap of CeO2. Oxygen vacancies help to increase the level of Ce +3 by preventing the recombination of charge centres. Regenerative nano-ceria oxidation-reduction cycles for ROS scavenging proceed, as presented in Figure 12: Due to the enzymatic activity of cerium oxide NPs, it has recently been explored for the sensing of molecules in a biological environment. Cerium NPs can be employed as inorganic probes for the detection of H2O2, dopamine, glutamate polyphenols and glucose, and they can replace soluble organic redox dyes, oxidase and peroxidase enzymes Due to the enzymatic activity of cerium oxide NPs, it has recently been explored for the sensing of molecules in a biological environment. Cerium NPs can be employed as inorganic probes for the detection of H 2 O 2 , dopamine, glutamate polyphenols and glucose, and they can replace soluble organic redox dyes, oxidase and peroxidase enzymes [168][169][170]. In relation to fluorescence imaging, cerium NPs have weak fluorescence, which can be improved by doping with highly fluorescence elements, such as europium (Eu +3 ) [171,172]. Likewise, the magnetic properties of cerium NPs can also be improved by doping with certain magnetic elements, such as gadolinium (Gd), dysprosium (Dy) and holonium (Ho) for MRI applications [163,173,174]. Other interesting approaches, such as core shell and cerium nanodots or quantum dot-encrusted structures have been reported to create composite theranostic nanostructures. Morlando et al. reported cerium nanodot-encrusted titania (TiO 2 ) for UV absorption and biocompatible ROS scavenging applications [175]. Ceria-encrusted TiO 2 NPs were synthesised by a combination of thermal precipitation and chemical precipitation approaches [176]. The reported nanostructure showed biocompatibility, high UV absorption and ROS scavenging [176]. Morlando et al. synthesised cerium nanodot-encrusted rutile TiO 2 rods by hydrothermal processing [177]. The encrustation of rutile TiO 2 rods increased the biocompatibility and lowered the photocatalytic activity of TiO 2 , and resulted in high UV absorption [177]. In another study conducted by Morlando et al., CeO 2 nanodot-encrusted TiO 2 NPs were synthesised using the precipitation technique [175]. The morphology of the synthesised encrusted nanostructure studied by TEM is presented in Figure 13a. The presence of CeO 2 nanodots on the surface facilitated ROS scavenging by reducing the photocatalytic activity of TiO 2 NPs. The synthesised nanostructure exhibited a very negligible dye degradation at 5 and 10 atomic% of CeO 2 compared to TiO 2 NPs due to reduced photocatalytic activity (Figure 13b). High cell viability (HaCaT cell line) was also observed for the encrusted TiO 2 NPs (5 and 10 atomic% of CeO 2 ) with reference to the positive control (TiO 2 NPs), which was slightly lower than CeO 2 NPs (Figure 13c) [175]. on the surface facilitated ROS scavenging by reducing the photocatalytic activity of TiO2 NPs. The synthesised nanostructure exhibited a very negligible dye degradation at 5 and 10 atomic% of CeO2 compared to TiO2 NPs due to reduced photocatalytic activity ( Figure  13b). High cell viability (HaCaT cell line) was also observed for the encrusted TiO2 NPs (5 and 10 atomic% of CeO2) with reference to the positive control (TiO2 NPs), which was slightly lower than CeO2 NPs (Figure 13c) [175]. Thus, cerium oxide NPs have emerged as powerful antioxidants and have been reported for their multi-enzymatic mimetic activity, and efficient ROS and NOS scavenging properties. The theranostic applications of Ce-based nanostructures are detailed in Figure  14. Thus, cerium oxide NPs have emerged as powerful antioxidants and have been reported for their multi-enzymatic mimetic activity, and efficient ROS and NOS scavenging properties. The theranostic applications of Ce-based nanostructures are detailed in Figure 14.

Oxygen-Deficient Lanthanum Oxide
Lanthanum (La) is a rare-earth (RE) element and is finding many technological and industrial applications in the form of lanthanum oxide (La2O3), such as chemical catalysts, laser material, precision optical glasses, electrode material, light-emitting material (blue powder) and hydrogen storage material [178,179]. It is also employed in many biomedical applications, such as targeted drug delivery within the body, suppression of bacteria and viruses [180][181][182], binding agent for several proteins, calcium channel suppression, fluorescence dyes and ROS scavenging activity [181,183]. In the electronic configuration of La, 6S electrons are drawn inward due to the poor shielding of the nuclear charge by 4f electrons and results in the contraction of the atomic radius. The filling of the 4f shell increases with the increase in the atomic number, whereas 5d 1 configuration appears in La, Ce, Gd and Lu [184][185][186]. The availability of 4f and 5d electrons for reaction imparts unique magnetic, fluorescent, electrical and catalytic properties in rare-earth oxides [182].
The removal of surface oxygen atoms from the surface of La2O3 can affect the oxidation state, catalytic properties and biocompatibility. Rehman et al. reported oxygen-deficient La2O3 synthesis through the spray pyrolysis method [187]. SEM imaging (Figure 15a)

Oxygen-Deficient Lanthanum Oxide
Lanthanum (La) is a rare-earth (RE) element and is finding many technological and industrial applications in the form of lanthanum oxide (La 2 O 3 ), such as chemical catalysts, laser material, precision optical glasses, electrode material, light-emitting material (blue powder) and hydrogen storage material [178,179]. It is also employed in many biomedical applications, such as targeted drug delivery within the body, suppression of bacteria and viruses [180][181][182], binding agent for several proteins, calcium channel suppression, fluorescence dyes and ROS scavenging activity [181,183]. In the electronic configuration of La, 6S electrons are drawn inward due to the poor shielding of the nuclear charge by 4f electrons and results in the contraction of the atomic radius. The filling of the 4f shell increases with the increase in the atomic number, whereas 5d 1 configuration appears in La, Ce, Gd and Lu [184][185][186]. The availability of 4f and 5d electrons for reaction imparts unique magnetic, fluorescent, electrical and catalytic properties in rare-earth oxides [182].
The removal of surface oxygen atoms from the surface of La 2 O 3 can affect the oxidation state, catalytic properties and biocompatibility. Rehman et al. reported oxygen-deficient La 2 O 3 synthesis through the spray pyrolysis method [187]. SEM imaging (Figure 15a) reveals the hollow, sphere-like morphology of the synthesised nanostructure, where each individual sphere consists of nanocrystals. The nanostructure recorded a higher UV-Vis absorption than commercial La 2 O 3 (Figure 15b). One interesting feature of the nanostructure is its ROS scavenging property, as shown in Figure 15c, which indicates higher ROS scavenging activity at pH 4.5 than pH 3.5 compared to the negative (dye only) and positive (H 2 O 2 ) controls. The reported structure exhibited excellent ROS scavenging activity in a concentrated H 2 O 2 environment. The nanostructure exhibited a decreased bandgap, high UV absorption and antioxidant behaviour compared to commercial La 2 O 3 [187]. The nanostructures based on La 2 O 3 can be exploited for ROS scavenging applications if synthesised under controlled processing conditions. Liu et al. reported the antioxidant activity of La +3 in the roots of rice seedlings. The internalisation of La +3 was observed by laser scanning confocal microscopy. A H2DCFDA probe was employed to study the change in ROS concentration [188]. The results of this study show a decrease in ROS level at a concentration of 0.05 mM of La +3 [157]. Wang et al. reported the ROS scavenging mechanism and protection effect against oxidative stress in soybean seeds [189].
The La2O3 nanostructure synthesised by the spray precipitation method for biological applications was reported by Rehman et al. [182]. Mostly, an irregular or thick plate-like morphology was observed in the SEM imaging (Figure 16a). The UV absorption measurements of the spray-precipitated nanostructure (La2O3) showed higher absorption in the 200-500 nm range than the commercial sample. The dye degradation assay in the presence of a P25 photocatalyst exhibited a protective effect against ROS generation through scavenging. A lower dye degradation (~44%) was recorded in the presence of La2O3 NPs compared to the P25-only assay (~96%) shown in Figure 16c. A confocal microscopy study showed the cellular (HaCaT cell line) internalisation of NPs (Figure 16d) [182]. The cytotoxicity data revealed the biocompatible nature of the nanostructure, even at a higher concentration (500 mg L −1 ) with reference to ZnO (Figure 16e). Antioxidant property evaluations by the DCF fluorescent assay on HaCaT cells with reference to NAC and H2O2 (positive control) are shown in Figure 16f. A higher ROS scavenging was observed in La2O3 NP-treated cells than NAC-treated cells compared to the positive control. ROS scavenging in non-malignant HaCaT cells lowered ROS-induced oxidative stress [182]. The most dominating mechanism of ROS scavenging is the interconversion of La2O3−x, La(OH)3 and La2O3 is shown in Figure 17. Liu et al. reported the antioxidant activity of La +3 in the roots of rice seedlings. The internalisation of La +3 was observed by laser scanning confocal microscopy. A H 2 DCFDA probe was employed to study the change in ROS concentration [188]. The results of this study show a decrease in ROS level at a concentration of 0.05 mM of La +3 [157]. Wang et al. reported the ROS scavenging mechanism and protection effect against oxidative stress in soybean seeds [189].
The La 2 O 3 nanostructure synthesised by the spray precipitation method for biological applications was reported by Rehman et al. [182]. Mostly, an irregular or thick platelike morphology was observed in the SEM imaging (Figure 16a). The UV absorption measurements of the spray-precipitated nanostructure (La 2 O 3 ) showed higher absorption in the 200-500 nm range than the commercial sample. The dye degradation assay in the presence of a P25 photocatalyst exhibited a protective effect against ROS generation through scavenging. A lower dye degradation (~44%) was recorded in the presence of La 2 O 3 NPs compared to the P25-only assay (~96%) shown in Figure 16c. A confocal microscopy study showed the cellular (HaCaT cell line) internalisation of NPs (Figure 16d) [182]. The cytotoxicity data revealed the biocompatible nature of the nanostructure, even at a higher concentration (500 mg L −1 ) with reference to ZnO (Figure 16e). Antioxidant property evaluations by the DCF fluorescent assay on HaCaT cells with reference to NAC and H 2 O 2 (positive control) are shown in Figure 16f. A higher ROS scavenging was observed in La 2 O 3 NP-treated cells than NAC-treated cells compared to the positive control. ROS scavenging in non-malignant HaCaT cells lowered ROS-induced oxidative stress [182]. The most dominating mechanism of ROS scavenging is the interconversion of La 2 O 3−x , La(OH) 3 Figure 17.

Tantalum Oxide Nanostructures
Tantalum oxide (Ta2O5)-based nanostructures are being employed in CT contrast in lab scale diagnoses [190]. Materials with high Z and density (ρ) are considered suitable to achieve a better resolution in CT imaging. A tantalum (Ta) nanostructure can absorb more

Tantalum Oxide Nanostructures
Tantalum oxide (Ta 2 O 5 )-based nanostructures are being employed in CT contrast in lab scale diagnoses [190]. Materials with high Z and density (ρ) are considered suitable to achieve a better resolution in CT imaging. A tantalum (Ta) nanostructure can absorb more X-rays due to high Z and ρ (75, 16.4 g cm −3 ) and can be an excellent choice for a high-performance contrast agent. The choice of Ta 2 O 5 NPs for a contrast agent is based on its biocompatible nature, compared with Au NPs, because Au NPs also offer an excellent choice for radiosensitisation, but, at the same time, they are toxic to many cell lines and tissues (Table 7) [190,191]. Thus, Ta 2 O 5 NPs exhibited biocompatible and theranostic properties in cell culture studies.
Engels et al. studied Ta 2 O 5 NPs for radiation dose enhancement to treat the tumour cells. In the MDCK cell line, Ta 2 O 5 NPs were internalised (black-brown spots) successfully, as shown in Figure 18a, observed by light microscopy [192]. Another tumour cell line (9L gliosarcoma) was irradiated with a radiation beam of energy 90 keV with a specific width and pitch and at 50 µg mL −1 and 500 µg mL −1 concentrations, compared to the control for the purpose of radiation dose enhancement (Figure 18b,c). It can be seen that "cell survival fraction" is at a minimum level at a high NP dose (500 µg m L −1 ) with reference to control cells. NPs treated with 500 µg mL −1 showed a lower cell survival fraction compared to the control than lower NP concentrations (50 µg mL −1 ) when irradiated with 10 MV X-ray beams [193]. Nanomaterials 2022, 12, x FOR PEER REVIEW 25 of 42 X-rays due to high Z and ρ (75, 16.4 g cm −3 ) and can be an excellent choice for a highperformance contrast agent. The choice of Ta2O5 NPs for a contrast agent is based on its biocompatible nature, compared with Au NPs, because Au NPs also offer an excellent choice for radiosensitisation, but, at the same time, they are toxic to many cell lines and tissues (Table 7) [190,191]. Thus, Ta2O5 NPs exhibited biocompatible and theranostic properties in cell culture studies. Engels et al. studied Ta2O5 NPs for radiation dose enhancement to treat the tumour cells. In the MDCK cell line, Ta2O5 NPs were internalised (black-brown spots) successfully, as shown in Figure 18a, observed by light microscopy [192]. Another tumour cell line (9L gliosarcoma) was irradiated with a radiation beam of energy 90 keV with a specific width and pitch and at 50 µg mL −1 and 500 µg mL −1 concentrations, compared to the control for the purpose of radiation dose enhancement (Figure 18b,c). It can be seen that "cell survival fraction" is at a minimum level at a high NP dose (500 µg m L −1 ) with reference to control cells. NPs treated with 500 µg mL −1 showed a lower cell survival fraction compared to the control than lower NP concentrations (50 µg mL −1 ) when irradiated with 10 MV X-ray beams [193]. Pictures are reproduced with permission from [192,193], copyright 2016, Elsevier, and represent an overview and general trend of results.
Oxygen-deficient tantalum oxide (TaOx) offers a better choice than Ta2O5 for higher CT visualisation, as reported by Chakravarty et al. [194]. Depending upon the x value, TaOx has higher concentration of Ta and higher density than Ta2O5 [194]. Both the higher density and higher concentrations of Ta aid in greater X-ray attenuations to result in higher CT contrasts. The development of TaOx nanocrystals was first reported by Hyeon et al. synthesised through the sol-gel method using the precursor tantalum (v) ethoxide [195]. Table 7. In vitro cellular behaviour of Ta2O3 and TaOx with reference to size, shape and synthesis method.

Cell Line NP Size and Shape Synthesis Method Effect
HEK 293 cell line TaOx nanocrystals (9-12 nm) Sol-gel No significant cytosolic dissolution under cytosolic and lysosomal conditions, high in vitro cell viability [194]. RAW 264.7 macrophage cells TaOx nanocrystals (9-12) nm Sol-gel No significant cell toxicity, and produced effective CT contrast [194].  [192,193], copyright 2016, Elsevier, and represent an overview and general trend of results.
Oxygen-deficient tantalum oxide (TaO x ) offers a better choice than Ta 2 O 5 for higher CT visualisation, as reported by Chakravarty et al. [194]. Depending upon the x value, TaO x has higher concentration of Ta and higher density than Ta 2 O 5 [194]. Both the higher density and higher concentrations of Ta aid in greater X-ray attenuations to result in higher CT contrasts. The development of TaOx nanocrystals was first reported by Hyeon et al. synthesised through the sol-gel method using the precursor tantalum (v) ethoxide [195]. Table 7. In vitro cellular behaviour of Ta 2 O 3 and TaO x with reference to size, shape and synthesis method.

Cell Line NP Size and Shape Synthesis Method Effect
HEK 293 cell line TaO x nanocrystals (9-12 nm) Sol-gel No significant cytosolic dissolution under cytosolic and lysosomal conditions, high in vitro cell viability [194].
RAW 264.7 macrophage cells TaO x NPs (5-15 nm) Micro-emulsion Maintained high in vitro cell viability, effective in vitro fluorescence and CT contrast [195].

Precipitation and calcination
Non-toxic over a wide range of concentrations. cell death in the localised radiation therapy and due to radiosensitivity of 9L cells [191].
Madin-Darby Canine Kidney (MDCK) Precipitation and calcination Non-toxic over a wide range of concentrations [191].
Mammalian (HeLa) cell line TaO x core shell structure (~10 nm) Aqueous sol-gel method-based reverse-micelles assembly Less toxicity and inflammation than commonly used adhesive CA-Lp. Multifunctional X-ray fluorescence and CT properties [196].
The effect of high Z and ρ on X-ray attenuation can be expressed by the following relation [190]: where µ is the X-ray attenuation coefficient, ρ the density, Z the atomic number, A the atomic mass and E the X-ray energy.
In clinical CT, X-ray attenuation is measured in Hounsfield units (HUs). The value of HUs can be determined from the corresponding value of µ by the following formula [190,197]: CT devices are calibrated with respect to water; on this scale, the radiodensity of water is taken as 0 HU, whereas air is 1000 HU. The value of HU for bone may be about +1000 and for soft tissues, such as protein, it may vary between −100 to +100 HU. For the visualisation of the tissue of interest, a minimum difference of about 50-100 HU is requisite; however, the greater the difference, the better the visualisation [198].

Bismuth Oxide and Hydroxide Nanostructures
Bismuth (Bi)-containing NPs have recently attracted much interest due to their multifunctional and theranostic properties. Bismuth has a high atomic number (Z = 83), which can offer excellent X-ray attenuation (5.74 cm 2 kg −1 at 100 keV) [199,200]. Owing to the range of Bi properties, such as high surface area, chemical inertness, low toxicity, diamagnetism, antibacterial activity, catalytic performance, strong near-infrared absorbance and high efficiency of photothermal conversion [201,202], it can be employed as a multifunctional and theranostic agent. The use of Bi compounds in conventional medicines dates back to the 18th century [203]. It has been employed in various pharmaceutical products to treat gastrointestinal disorders, syphilis and hypertension. Nowadays, the use of Bi-based NPs has been expanded to advance diagnostic and therapeutic applications, such as X-ray radiotherapy, biosensing, bioimaging, cancer therapy, photothermal therapy, antimicrobial formulations, ROS-based therapy and tissue engineering [202,204]. A variety of Bi-based nanostructures, such as Bi NPs, bismuth oxide (Bi 2 O 3 ) NPs, Bi(OH) 3 NPs, bismuth sulphide (Bi 2 S 3 ), bismuth selenide (Bi 2 Se 2 ), bismuth ferrite (BiFeO 3 ), bismuth tungstate (Bi 2 WO 6 ) and bismuth dimercaptopropanol (BisBAL), can be synthesised using a suitable synthesis method. Synthesis methods, such as hydrothermal processing, chemical precipitation, solgel technique, thermal evaporation, micro-emulsion, sonochemical synthesis, solvothermal synthesis and microwave irradiation, can be selectively employed for the desired size and shape of NPs.
The use of Bi-based nanostructures is rapidly expanding in the field of cancer diagnosis and treatment as they have shown promising results. Stewart et al. synthesised Bi 2 O 3 NPs by the precipitation method and reported the selective ROS-dependent toxicity in malignant (9L cell line) and non-malignant (MDCK cell line) cells [204]. Bogus et al.
reported biocompatible Bi(OH) 3 with low photocatalytic activity and good UV absorption properties [205]. In the present study, Bi(OH) 3 exhibited low toxicity towards MDCK cells, which resulted in higher cell viability (~83%) at a tested dose of 25 µg mL −1 over a period of 24 h (Figure 19c), whereas higher toxicity was observed in MCF-7 and 9L (with survival fraction~20 and 5%) cells. The compared data of Bi 2 O 3 NP treatment also showed similar trends of toxicity in malignant (MCF-7 and 9L) cells; however, the cell survival fraction lowered to 60% in treated MDCK cells at a 25 µg mL −1 NP concentration. The confocal microscopy of strained (Hoechest and H 2 DCFDA) 9L cells showed the cellular internalisation of Bi(OH) 3 NPs (Figure 19a). The treatment of 9L cells with Bi(OH) 3 and Bi 2 O 3 NPs resulted in the highest cellular apoptosis after 24 and 15 h, respectively, as shown in Figure 19b. microscopy of strained (Hoechest and H2DCFDA) 9L cells showed the cellular internalisation of Bi(OH)3 NPs (Figure 19a). The treatment of 9L cells with Bi(OH)3 and Bi2O3 NPs resulted in the highest cellular apoptosis after 24 and 15 h, respectively, as shown in Figure  19b.
Recently, Yang et al. developed lipid (1,2-dilauroyl-sn-glycero-3-phosphocholine, abbreviated as DLPC)-coated Bi NPs for efficient photothermal therapy, CT imaging and tumour irradiation by NIR light irradiation [201]. Bi@DLPC NPs showed a higher cellular uptake and tumour accumulation via the EPR effect, and changed cell membrane permeability and caused mitochondrial dysfunction. A variety of Bi-based nanostructures have been prepared for theranostic applications using different synthesis techniques, including NPs, coated NPs, functionalised NPs and compounds of Bi with different elements. A brief summary of the synthesis method, size, shape and in vitro behaviour of different reported structures is presented in Table 8. Recently, Shahbazi et al. published a comprehensive review on the multifunctional application of Bi-based nano-and composite structures, and also highlighted the synthesis methods used for the development or functionalisation of Bi-based NPs [202]. Where **** p ˂ 0.0001, *** p ˂ 0.001, ** p < 0.01 and *p < 0.05 vs. control. Images and graphs are reproduced with permission from [205], copyright 2018, Elsevier, and represent the overall trend of results. Higher cellular internalisation, increased ROS generation, induced higher toxicity and, hence, lowered cell viability [205]. Recently, Yang et al. developed lipid (1,2-dilauroyl-sn-glycero-3-phosphocholine, abbreviated as DLPC)-coated Bi NPs for efficient photothermal therapy, CT imaging and tumour irradiation by NIR light irradiation [201]. Bi@DLPC NPs showed a higher cellular uptake and tumour accumulation via the EPR effect, and changed cell membrane permeability and caused mitochondrial dysfunction. A variety of Bi-based nanostructures have been prepared for theranostic applications using different synthesis techniques, including NPs, coated NPs, functionalised NPs and compounds of Bi with different elements. A brief summary of the synthesis method, size, shape and in vitro behaviour of different reported structures is presented in Table 8. Recently, Shahbazi et al. published a comprehensive review on the multifunctional application of Bi-based nano-and composite structures, and also highlighted the synthesis methods used for the development or functionalisation of Bi-based NPs [202]. Hot injection method Dose-dependent uptake, good biocompatibility even at higher doze (2 mg Bi mL −1 , excellent for CT imaging [206]. Solution-based method using poly(vinylpyrrolidone) Mitochondria-mediated intrinsic cell apoptosis, G0/GI cell cycle arrest, TrxR inhibition, ROS generation, X-rays induced apoptosis, increased radio-sensitisation effect. Excellent photoacoustic imaging [210].

MCF-7 cell line Bi 2 O 3 (unknown 14 nm) Commercial
Increased ROS generation, SOD and CAT activity, and increased GSH concentration, mitochondrion dysfunction, DNA damage and cellular apoptosis [212].

Magnesium Oxide Nanostructure
Currently, research is being conducted on therapeutic aspects, such as the antibacterial, cytotoxic and antithrombotic properties of MgO structures. MgO has also been used in nano-cryosurgery for the treatment of cancer [214,215]. In addition to the research on the therapeutic aspects of MgO nanostructures, the focus has also been shifted to the imaging capabilities of MgO. Extensive point defects in the MgO structure have been studied to exploit the maximum photoluminescence effect. Near-infrared signals from MgO crystals excited by 325 nm and 532 nm radiation for the broad fluorescence band have been studied by Prucnal et al. [216]. This study aligned the 800 nm broad line to Cr +3 substitutional defects as excited by a 532 nm laser, and the line above 850 nm assigned to V +2 substitutional defects. The lines above 850 nm are strongly temperature dependent with a maximum intensity at 15 K, and linked to a phonon-assisted transition [216]. Kunz et al. reported the emission at 700 nm in MgO crystals by excitation at 5-7 K, which is linked to Cr +3 defects [217]. The fluorescence properties help to track the interaction of MgO NPs inside cells and other biological entities. In addition to intrinsic fluorescence, MgO NPs also have good biocompatibility and biodegradability. The combination of biocompatibility, therapeutic effect and imaging capabilities make MgO NPs a theranostic agent for biological applications. MgO NPs can be employed in cutting-edge treatment by fluorescence-guided surgery. These theranostic NPs can help to differentiate between the normal surrounding tissues from tumour tissues through fluorescence-guided therapy.  Table 9. − reacts with the H + ion to form HO • , which increases the antibacterial activity. The release of Mg +2 also increases antibacterial activity by ROS generation and can cause cellular enzyme deactivation and mitochondrial impairment. The generation of excessive ROS can cause oxidative stress and damage to the membrane and other cellular components, hence leading to cell necrosis (Table 9) [222]. O − 2 + H + → OH • In short, MgO NPs can increase the concentration of ROS (Figure 20), decrease the level of glutathione and increase lipid peroxidation in tumour cells [223]. Krishnamoorthy et al. reported a strong interaction between alkaline MgO NPs and acidic cancer cells [221], in addition to the MRI contrast properties, hyperthermia ability and nano-cryosurgery applications in the treatment of cancer also evaluated by Krishnamoorthy et al. [221]. They observed higher toxicity in malignant cell lines (SNU-A6, AGS) and recorded non-significant toxicity in a non-malignant human lung fibroblast (CCD-25Lu) cell line. This study confirmed the generation of ROS by MgO NPs that caused lipid peroxidation and oxidative stress-mediated cell death [221]. It has also been reported that MgO NPs are non-toxic and biocompatible towards many human cell lines under 300 µg mL −1 , which has been published in a study conducted by Mahmoud et al. [218]. They can be coated with antitumour drugs, such as albumin, doxorubicin and 2-Metoxyestradiol, to construct a more effective anticancer theranostic system [220]. Biocompatible and safe MgO NPs can be developed by green synthesis or functionalisation with non-toxic materials. These NPs can be an excellent choice for controlled therapy and the diagnosis of cancer.
published in a study conducted by Mahmoud et al. [218]. They can be coated with antitumour drugs, such as albumin, doxorubicin and 2-Metoxyestradiol, to construct a more effective anticancer theranostic system [220]. Biocompatible and safe MgO NPs can be developed by green synthesis or functionalisation with non-toxic materials. These NPs can be an excellent choice for controlled therapy and the diagnosis of cancer.  [224]. In another study, Amina et al. used MgO NPs as an anticancer agent. This study reported an increased amount of intracellular ROS in MgO NPtreated cells compared to control and chemotherapeutic drugs (paclitaxel), as shown in Figure 21d, e and f. The enhanced green fluorescence in the treated cells exhibited ROS formation, which caused an apoptotic effect in MCF-7 cells. The ROS-related fluorescence integrity of cells was quantified in the form of a bar graph, as shown in Figure 21g. A higher ROS formation in MgO NP-treated cells caused higher cellular apoptosis and, hence, higher fluorescence [224]. Furthermore, dual staining using acridine orange (AO) and ethidium bromide (EtBr) dyes was performed to assess the apoptosis induced by MgO NPs. The presence of green fluorescence caused the penetration of AO dye into plasma and the binding of the DNA of cells, where the green colour represents the viable cells. On the other hand, orange-red fluorescence was caused due to the penetration of EtBr through damaged cell membranes, indicating apoptotic and dead cells (Figure 21h,i and j). The quantification of the obtained results demonstrates an increased dead cell percentage relative to the viable cells (84.3 ± 0.01% dead and 15.7 ± 0.02% viable cells) in MgO NP-treated cells compared to the control (8.3 ± 0.07% dead and 91.8 ± 0.09% viable cells) and paclitaxel-treated (65.4 ± 0.06% dead and 34.6 ± 0.04% viable cells) groups, as shown in Figure 21k. The treatment of MCF-7 cells with MgO NPs resulted in the production of ROS, which caused oxidative stress-mediated cell death. Additionally, MgO NPs disrupted the membrane mitochondrial potential (MMP) and led to cell death through intrinsic pathways of apoptosis [224].  Figure 21d, e and f. The enhanced green fluorescence in the treated cells exhibited ROS formation, which caused an apoptotic effect in MCF-7 cells. The ROS-related fluorescence integrity of cells was quantified in the form of a bar graph, as shown in Figure 21g. A higher ROS formation in MgO NP-treated cells caused higher cellular apoptosis and, hence, higher fluorescence [224]. Furthermore, dual staining using acridine orange (AO) and ethidium bromide (EtBr) dyes was performed to assess the apoptosis induced by MgO NPs. The presence of green fluorescence caused the penetration of AO dye into plasma and the binding of the DNA of cells, where the green colour represents the viable cells. On the other hand, orange-red fluorescence was caused due to the penetration of EtBr through damaged cell membranes, indicating apoptotic and dead cells (Figure 21h,i and j). The quantification of the obtained results demonstrates an increased dead cell percentage relative to the viable cells (84.3 ± 0.01% dead and 15.7 ± 0.02% viable cells) in MgO NPtreated cells compared to the control (8.3 ± 0.07% dead and 91.8 ± 0.09% viable cells) and paclitaxel-treated (65.4 ± 0.06% dead and 34.6 ± 0.04% viable cells) groups, as shown in Figure 21k. The treatment of MCF-7 cells with MgO NPs resulted in the production of ROS, which caused oxidative stress-mediated cell death. Additionally, MgO NPs disrupted the membrane mitochondrial potential (MMP) and led to cell death through intrinsic pathways of apoptosis [224]. Where ** p < 0.01 and * p < 0.05 and are considered significant. Images (a-c) are reproduced with permission from [224], copyright 2021, Nanomaterials (MDPI), whereas images (d-f,hj) and charts (g,k) are reproduced with permission from [225], copyright 2020, PLOS One.

Elimination of Nanoparticles from the Body after Treatment
The elimination of nanoparticles from the body after their intended use is required in order to avoid long-term toxicity and other health complications. Currently, there are different elimination pathways that highly depend upon the size, shape and biodegradability of nanoparticles. Most nanoparticles are resistant to metabolism and renal secretion because of their large size [226]. Intravenously administered nanoparticles can be eliminated by two main pathways: (1) renal elimination and (2) hepatobiliary elimination [227]. Choi et al. conducted a renal excretion experiment using nanoparticles with different hydrodynamic diameters and showed that quantum dots with a diameter < 5.5 nm exhibited efficient renal excretion due to the limitation of the pore size of glomerular filtration. Various studies have been performed to optimise the renal elimination of nanoparticles by the fine tuning of size, shape and surface charge.
Gold nanoparticles are FDA-approved metallic nanoparticles that are employed for various biological roles. Their elimination mechanism is also crucial after treatment, according to various studies.
Au nanoparticles with a hydrodynamic diameter < 5.5 nm are easily secreted by the renal rout; however, larger Au nanoparticles can accumulate in the spleen and liver and follow the reticuloendothelial rout for elimination [228,229]. W. Poon et al. reported the hepatobiliary elimination of non-biodegradable Au nanoparticles and found that Kupffer and sinusoidal endothelial cells are major abstractions in the elimination of nanoparticles. These nonparenchymal cells have a high phagocyte affinity for NPs and most NPs are trapped by these cells upon their first interaction. The elimination through this pathway Where ** p < 0.01 and * p < 0.05 and are considered significant. Images (a-c) are reproduced with permission from [224], copyright 2021, Nanomaterials (MDPI), whereas images (d-f,h-j) and charts (g,k) are reproduced with permission from [225], copyright 2020, PLoS ONE.

Elimination of Nanoparticles from the Body after Treatment
The elimination of nanoparticles from the body after their intended use is required in order to avoid long-term toxicity and other health complications. Currently, there are different elimination pathways that highly depend upon the size, shape and biodegradability of nanoparticles. Most nanoparticles are resistant to metabolism and renal secretion because of their large size [226]. Intravenously administered nanoparticles can be eliminated by two main pathways: (1) renal elimination and (2) hepatobiliary elimination [227]. Choi et al. conducted a renal excretion experiment using nanoparticles with different hydrodynamic diameters and showed that quantum dots with a diameter < 5.5 nm exhibited efficient renal excretion due to the limitation of the pore size of glomerular filtration. Various studies have been performed to optimise the renal elimination of nanoparticles by the fine tuning of size, shape and surface charge.
Gold nanoparticles are FDA-approved metallic nanoparticles that are employed for various biological roles. Their elimination mechanism is also crucial after treatment, according to various studies.
Au nanoparticles with a hydrodynamic diameter < 5.5 nm are easily secreted by the renal rout; however, larger Au nanoparticles can accumulate in the spleen and liver and follow the reticuloendothelial rout for elimination [228,229]. W. Poon et al. reported the hepatobiliary elimination of non-biodegradable Au nanoparticles and found that Kupffer and sinusoidal endothelial cells are major abstractions in the elimination of nanoparticles. These nonparenchymal cells have a high phagocyte affinity for NPs and most NPs are trapped by these cells upon their first interaction. The elimination through this pathway requires further study for understanding NPs' interaction with biological components, such as the bile duct, hepatocytes and intestines [227].
The elimination of silver-based NPs is also challenging, Zande et al. reported silver NPs' uptake and elimination in rat organs. In this study, silver NPs were cleared from most rat organs, except the brain and testis [230]. Similarly, other inorganic NPs are being investigated for complete removal from the body in a specific time limit. Inorganic NPs are largely sequestered from the blood by liver and spleen, and thereby increase the chances of accumulation. A sever uptake of inorganic NPs can be avoided by poly(ethylene glycol) coating, but it does not guarantee complete elimination [231,232]. The size, shape and surface charge affect the renal clearance of inorganic nanoparticles from the body. Inorganic NPs are usually developed with controlled properties as an efficient option for early diagnosis and therapy. These properties include: theranostic characteristics, high clearance rate, good physiological stability, low binding affinity for biomolecules, low accumulation, high specific target capability, short distribution life and high permeability and retention [231]. Currently, various studies are being conducted to develop composite core-shell structures with shells consisting of biodegradable molecules and cores having inorganic quantum-sized particles (<6 nm) [231,233,234].

Conclusions
The physio-chemical properties of nanomaterials play a critical role in their cytotoxicity and multifunctional role. Au, Ag-based nanostructures have a very effective role in malignant tumour treatment due to their antiviral and anti-infective properties, but, at the same time, they produced toxicity in normal cells, such as HaCaT, human foetal osteoblasts and human HepG2 cells. Similarly, the oxide nanostructures of Mn and Fe increased oxidative stress through ROS generation, which is a critical factor for oxidative bursts in cancer cells. However, they also caused toxicity in normal cells, such as CCL-149, L929, BEAS-2B and HepG2. Increased ROS production and nanotoxicity decreased cell proliferation and viability. The damage of cell membrane, mitochondrion, DNA and depletion of necessary enzymes and proteins led to cell death, which are desired in tumour cells. In a few studies, it has been reported that the NPs of Au, Ag and Mn also caused genotoxicity and neurotoxicity.
The toxic behaviour of some metal/metal oxide NPs systems, particularly, naked NPs towards normal cells, is a matter of concern. Many biocompatible systems with selective toxicity in the microenvironment have been synthesised using controlled processing parameters, such as a suitable chemical selection and synthesis environment.
Recently, developed superparamagnetic nanostructures of γ-Fe 2 O 3 showed higher toxicity in MDA-MB-231 and MCF-7 cells compared to HaCaT cells. A confocal observation also showed their fluorescence imaging capability. Oxygen-deficient La 2 O 3 synthesised by spray pyrolysis and the spray precipitation method exhibited higher UV absorption and ROS scavenging in HaCaT cells. Similarly, ITO nanoparticles that were synthesised under a controlled atmosphere resulted in a high level of ROS in MDA-MB-231 and MCF-7 cell lines compared to the MCF-10A cell line. The selective generation of ROS and fluorescence imaging features of ITO NPs presented them as suitable candidates for cancer theranostics. Ta 2 O 5 NPs were successfully employed in radiation dose enhancement and fluorescence imaging. They also showed a good drug loading capability. Enhanced biocompatibility and increased UV absorption was witnessed in the case of CeO 2 nanodot-encrusted TiO 2 nanostructures. Bi-based nanostructures showed excellent theranostic behaviour in malignant tumour (9L and MCF-7) cells. An increased level of ROS caused an antiproliferative effect in MCF-7 cells and excellent traceability when treated with MgO NPs. Nanostructures exhibiting size-and shape-dependent theranostic properties, such as star-, cube-and rod-shaped nanoparticles, caused higher toxicity than spherical-shaped nanostructures. Similarly, nano-sized particles in the 10-30 nm range offered excellent theranostic properties, and even quantum-sized particles showed excellent tumour penetration, drug loading and diagnostic capabilities.
The imaging (such as fluorescence, MRI and CT) and therapeutic capabilities (such as hyperthermia, photothermal, ROS generation and ultrasonic therapy) of efficient nanosystems were exhibited in the tumour microenvironment. The effect on normal cells during the treatment was highlighted. In summary, metal and metal oxide nanosytems have proven to be efficient in selective tumour diagnosis and treatment. The reported toxicity towards non-malignant cells in a few cases can be minimised through different approaches, such as encrustation, encapsulation, polymer coatings, core-shell structures, NP surface binding and inert atmosphere annealing to increase the biocompatibility and effectiveness of disease treatment of theranostic nanosystems. The presented summary of the critical features of nanostructures will serve as a fundamental tool to analyse, select and modify the properties of existing nanosystems in order to develop an efficient drug/system that selectively generates oxidative stress in tumour cells. The developed nanostructures may generate selective toxicity due to controlled ROS generation alongside diagnostic properties, and hence can offer safe, efficient and economic treatment options. Furthermore, a comprehensive study on the reported individual nanotheranostic systems (coated and uncoated) covering in vivo performance will be conducted to facilitate the easy selection of nanosystems for a particular use or research.  Data Availability Statement: The study did not report any data.